Filter
2917
Filtered Results: 2917
Text search:
Drug
Resistance
Featured
Recommendations
307
New Publications
749
Language
Document type
No document type
1629
Studies & Reports
453
Guidelines
442
Manuals
133
Strategic & Response Plan
106
Fact sheets
58
Training Material
48
Situation Updates
15
Infographics
13
Resource Platforms
7
Online Courses
5
Brochures
3
Videos
3
App
2
Countries / Regions
India
156
Global
95
South Africa
81
Kenya
79
Western and Central Europe
75
Ethiopia
61
Uganda
53
Tanzania
51
Nepal
48
Eastern Europe
47
Africa
45
Zambia
42
Nigeria
40
Latin America and the Carribbean
38
Liberia
37
Sierra Leone
34
Malawi
32
Namibia
32
Ghana
31
Philippines
31
Myanmar / Burma
30
Bangladesh
29
Rwanda
28
Asia
26
Cambodia
23
Lesotho
22
South–East Asia Region
22
Zimbabwe
20
Ukraine
19
Senegal
19
Russia
19
Indonesia
19
Botswana
14
Congo, Democratic Republic of
13
Cameroon
12
Mozambique
12
Colombia
11
Venezuela
10
Syria
9
Thailand
8
Albania
8
Burkina Faso
8
West and Central Africa
8
Middle East and North Africa
8
Eastern Europe and Central Asia
8
Eswatini/ Swaziland
8
Haiti
7
Germany
7
East and Southern Africa
7
Argentina
7
Pakistan
7
Tajikistan
6
USA
6
Vietnam
6
Benin
5
China
5
Laos
5
Guinea
5
Georgia
5
El Salvador
4
Iran
4
Peru
4
Western Pacific Region
4
Brazil
4
Sri Lanka
4
Sudan
4
Iraq
4
North Macedonia
3
Estonia
3
Afghanistan
3
Jordan
3
Paraguay
3
North America
3
Uruguay
3
Lebanon
3
Central African Republic
3
Mali
3
Bhutan
3
South Sudan
3
Somalia
3
Timor Leste/ East Timor
2
Mexico
2
Morocco
2
Armenia
2
Saudi Arabia
2
Gabon
2
France
2
Tunisia
2
Côte d’Ivoire / Ivory Coast
2
Papua New Guinea
2
Nicaragua
2
Moldova
2
Yemen
2
Honduras
2
Libya
2
Ecuador
2
Madagascar
2
Guatemala
2
Switzerland
1
Serbia
1
Turkey
1
Gambia
1
Kazakhstan
1
Canada
1
Fiji
1
Congo-Brazzaville
1
Niger
1
Qatar
1
Italy
1
Dominican Republic
1
Guinea-Bissau
1
Turkmenistan
1
Jamaica
1
Denmark
1
Belgium
1
Maldives
1
Mauritius
1
United Kingdom
1
Spain
1
Bolivia
1
Belize
1
Costa Rica
1
Oman
1
Panama
1
Egypt
1
Romania
1
Greece
1
Angola
1
Chad
1
Authors & Publishers
Publication Years
Category
Countries
1028
Clinical Guidelines
293
Public Health
119
Women & Child Health
81
Key Resources
72
Capacity Building
40
Pharmacy & Technologies
38
Annual Report MEDBOX
1
Toolboxes
TB
509
HIV
353
AMR
329
NTDs
119
Mental Health
113
Malaria
100
COVID-19
94
Pharmacy
74
Rapid Response
63
Caregiver
49
Planetary Health
48
NCDs
37
Ebola & Marburg
33
Global Health Education
32
Refugee
31
Health Financing Toolbox
21
Polio
17
Conflict
14
Cholera
13
Disability
11
Natural Hazards
8
Zika
5
Specific Hazards
3
Social Ethics
3
This study aimed to determine the drug resistance profile of Mycobacterium tuberculosis in Mozambique and concludes that M. tuberculosis resistance to antituberculosis drugs is high in Mozambique, especially in previously treated patients. The frequency of M. tuberculosis strains that were resistant...
Antimicrobial resistance is one of the most important threats to the health worldwide. Antimicrobial resistance or drug resistance is the reduction of the pharmaceutical effects of a drug against a disease or reduction of its effectiveness in improving the clinical signs of a disease. Antimicrobial ...
WHO’s sentinel surveys of acquired HIV resistance to dolutegravir among people receiving dolutegravir-containing antiretroviral therapy is intended for easy and frequent implementation. Results from sentinel surveys provide insight into the prevalence and year-over-year trends of dolutegravir resi...
Antimicrobials have been a critical public health tool since the discovery of penicillin in 1928, saving the lives of millions of people around the world. Today, however, the emergence of drug resistance is reversing the miracles of the past eighty years, with drug choices for the treatment of many ...
This study consists of a descriptive analysis of M. tuberculosis isolates from Beira Central Hospital, Mozambique, during 2014–2015, being the first report of a genotypic testing used to provide information about second line drug resistance in Mozambique.
BMC Infectious Diseases (2016) 16:423 DO...
Arsenical monotherapies were previously very successful for treating human African trypanosomiasis (HAT).
Melarsoprol resistance emerged as early as the 1970s and was widespread by the late 1990s.
Melarsoprol resistance represents the only example of widespread drug resistance in HAT patients wher...
Efficacious antimalarial medicines are critical to malaria control and elimination. Continuous monitoring of their efficacy is needed to inform treatment policies in malaria-endemic countries, and to ensure early detection of, and response to, drug resistance.
Specific measures are being taken within the National Tuberculosis Control Programme (NTP) to address the MDR TB problem through appropriate management of patients and strategies to prevent the propagation and dissemination of MDR TB.
The term "Programmatic Management of Drug Resistant TB" (PMD...
The term "Programmatic Management of Drug Resistant TB" (PMD...
This study addresses part of the Terms of Reference for a scoping report ‘An analysis of approaches to laboratory capacity strengthening for drug resistant infections in low and middle income countries’. It has been produced as a separate report because it is also very relevant for a second stud...
In 2019, an estimated 10 million individuals fell ill with tuberculosis (TB) and 3 million of them were not reported to have beendiagnosed and notified. The gap is proportionately even wider for drug-resistant TB. Of the estimated 465 000 patients with rifampicin-resistant and multi-drug resistant T...
9 June 2021
Since its launch, GLASS has expanded in scope and coverage and as of May 2021, 109 countries and territories worldwide have enrolled in GLASS. A key new component in GLASS is the inclusion of antimicrobial consumption (AMC) surveillance at the national level highlighted in this fourth G...
The WorldWide Antimalarial Resistance Network (WWARN) is a global collaborative platform that provides the malaria community with innovative tools and reliable evidence to help them understand and address antimalarial drug resistance. Using molecular surveyors and mapping tools, WWARN visualises the...
Antimicrobial agents like antibiotics are essential to treat some human and animal diseases. Microbes, such as bacteria, can develop resistance to antimicrobials meaning that a drug such as an antibiotic is no longer effective in treating the infection. The development of resistance is caused by the...
Historically, the discovery of the sulfa drugs in the 1930s and the subsequent development of penicillin during World War II ushered in a new era in the treatment of infectious diseases. Infections that were common causes of death and disease in the pre-...
Antibiotics have been a critical public health tool since the discovery of Penicillin in 1928, saving the lives of millions of people around the world. In developing country like ours, where the burden of treatable disease is very high and access to health facilities and laboratories is difficult, a...
Barbados currently has a rudimentary framework and capacity to address the issue of antimicrobial resistance. There however needs to be coordination of efforts and improvement in areas where gaps have been identified.Actions required include improved antibiotic stewardship in healthcare settings, pr...
This document outlines the concept and content of the WHO people-centred approach to addressing antimicrobial resistance (AMR) in the human health sector. The proposed approach recognizes and aims to address the challenges and health system barriers people face when accessing health services to prev...
These updates include shorter novel 6-month all-oral regimens for the treatment of multidrug- and rifampicin-resistant TB (MDR/RR-TB), with or without additional resistance to fluoroquinolones (pre-XDR-TB) as well as an alternative 9-month all-oral regimen for the treatment of MDR/RR-TB.
This Ra...
This document provides practical guidance on planning and implementing next-generation sequencing (NGS) technology for characterization of Mycobacterium tuberculosis complex (MTBC) bacteria. The aim is to detect mutations associated with drug resistance in the context of a surveillance system for tu...
The Libyan national action plan has been aligned with WHO five objectives. Analysis of the current situation and addressing the gaps and the needs to reach the main goal “one health” approach involves several national sectors and actors, including human and veterinary health, agriculture and foo...
